Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

Article Abstract:

Nitric oxide appears to lessen the effects of hypoxic respiratory failure in newborn infants. This condition of reduced oxygen supply to the lungs sometimes occurs in newborn infants. Researchers tested the effect of nitric oxide in 114 infants with hypoxic respiratory failure. Nitric oxide can dilate blood vessels in the lungs, thus increasing the oxygen supply. A control group of 121 infants received 100% oxygen. Mortality rates were similar in both groups but the infants receiving nitric oxide had significantly increased blood oxygen levels and were less likely to need extracorporeal membrane oxygenation.

Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1997
Physiological aspects, Infants (Newborn), Newborn infants, Hypoxia, Anoxia, Respiratory insufficiency, Pediatric respiratory diseases, Respiratory insufficiency in children

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn

Article Abstract:

Inhaled nitric oxide may be beneficial in babies with pulmonary hypertension. Pulmonary hypertension is high blood pressure in the lungs. Researchers randomly assigned 248 babies with pulmonary hypertension to receive inhaled nitric oxide or a placebo. Nitric oxide causes blood vessels to dilate. Only 38% of the babies who received nitric oxide required extracorporeal membrane oxygenation compared to 64% of the placebo group. Only 7% of the babies who received nitric oxide developed chronic lung disease compared to 20% of the placebo group.

Author: Clark, Reese H., Kueser, Thomas J., Walker, Marshall W., Southgate, W. Michael, Huckaby, Jeryl L., Perez, Jose A., Roy, Beverly J., Keszler, Martin, Kinsella, John P.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Neonatal pulmonary hypertension: urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function

Article Abstract:

A deficiency of arginine and nitic oxide may cause persistent pulmonary hypertension in newborn babies. Arginine is the precursor of nitric oxide and is produced in the series of enzymatic reactions that create urea. These babies may have a defect in urea production.

Author: Haines, Jonathan L., Pearson, DeLinda L., Dawling, Sheila, Walsh, William F., Christman, Brian W., Bazyk, Amy, Scott, Nathan, Summar, Marshall L.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001
Causes of

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Care and treatment, Nitric oxide, Persistent fetal circulation syndrome
Similar abstracts:
  • Abstracts: A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis
  • Abstracts: Training in firearm safety counseling in pediatric residency programs. Sun protection counseling by pediatricians
  • Abstracts: Juvenile chronic arthritis: epidemiology and genetics. Managing systemic lupus erythematosus. Signs and symptoms of systemic lupus erythematosus
  • Abstracts: Structural determinants associated with risk of human developmental toxicity. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment
  • Abstracts: Effect of insulin therapy on body fat distribution in NIDDM patients with secondary sulfonylurea failure: a preliminary report
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.